138 related articles for article (PubMed ID: 7673336)
1. Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma.
Talts JF; Weller A; Timpl R; Ekblom M; Ekblom P
J Cell Sci; 1995 Jun; 108 ( Pt 6)():2153-62. PubMed ID: 7673336
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice.
Fässler R; Sasaki T; Timpl R; Chu ML; Werner S
Exp Cell Res; 1996 Jan; 222(1):111-6. PubMed ID: 8549652
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids down-regulate the extracellular matrix proteins fibronectin, fibulin-1 and fibulin-2 in bone marrow stroma.
Gu YC; Talts JF; Gullberg D; Timpl R; Ekblom M
Eur J Haematol; 2001 Sep; 67(3):176-84. PubMed ID: 11737251
[TBL] [Abstract][Full Text] [Related]
4. Induction of mouse tenascin expression by a human sarcomatoid Wilms' tumor cell line growing in nude mice.
Talts JF; Aufderheide E; Sorokin L; Ocklind G; Mattsson R; Ekblom P
Int J Cancer; 1993 Jul; 54(5):868-74. PubMed ID: 7686890
[TBL] [Abstract][Full Text] [Related]
5. Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro.
Sakai T; Kawakatsu H; Ohta M; Saito M
J Cell Physiol; 1994 Jun; 159(3):561-72. PubMed ID: 7514613
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts.
Sakai T; Furukawa Y; Chiquet-Ehrismann R; Nakamura M; Kitagawa S; Ikemura T; Matsumoto K
J Cell Sci; 1996 Aug; 109 ( Pt 8)():2069-77. PubMed ID: 8856503
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids.
Matsumoto K; Tajima H; Okazaki H; Nakamura T
J Biol Chem; 1992 Dec; 267(35):24917-20. PubMed ID: 1459995
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts.
Ekblom M; Fässler R; Tomasini-Johansson B; Nilsson K; Ekblom P
J Cell Biol; 1993 Nov; 123(4):1037-45. PubMed ID: 7693719
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
[TBL] [Abstract][Full Text] [Related]
11. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways.
Rettig WJ; Erickson HP; Albino AP; Garin-Chesa P
J Cell Sci; 1994 Feb; 107 ( Pt 2)():487-97. PubMed ID: 7515896
[TBL] [Abstract][Full Text] [Related]
12. Tenascin: growth and adhesion modulation--extracellular matrix degrading function: an in vitro study.
Shrestha P; Sumitomo S; Lee CH; Nagahara K; Kamegai A; Yamanaka T; Takeuchi H; Kusakabe M; Mori M
Eur J Cancer B Oral Oncol; 1996 Mar; 32B(2):106-13. PubMed ID: 8736172
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-C induction by the diffusible factor epidermal growth factor in stromal-epithelial interactions.
Sakai T; Ohta M; Furukawa Y; Saga Y; Aizawa S; Kawakatsu H; Saito M
J Cell Physiol; 1995 Oct; 165(1):18-29. PubMed ID: 7559800
[TBL] [Abstract][Full Text] [Related]
14. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.
Topalovski M; Hagopian M; Wang M; Brekken RA
J Biol Chem; 2016 Oct; 291(42):22244-22252. PubMed ID: 27531748
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
17. Localization of transforming growth factor-beta-expressing cells and comparison with major extracellular components in aural cholesteatoma.
Lang S; Schilling V; Wollenberg B; Mack B; Nerlich A
Ann Otol Rhinol Laryngol; 1997 Aug; 106(8):669-73. PubMed ID: 9270431
[TBL] [Abstract][Full Text] [Related]
18. Expression of tenascin-C by human endometrial adenocarcinoma and stroma cells: heterogeneity of splice variants and induction by TGF-beta.
Vollmer G; Tan MI; Wünsche W; Frank K
Biochem Cell Biol; 1997; 75(6):759-69. PubMed ID: 9599665
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid enhances transforming growth factor-beta effects on extracellular matrix protein expression in human placental mesenchymal cells.
Lee MJ; Ma Y; LaChapelle L; Kadner SS; Guller S
Biol Reprod; 2004 May; 70(5):1246-52. PubMed ID: 14681196
[TBL] [Abstract][Full Text] [Related]
20. Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines.
Wilson KE; Bartlett JM; Miller EP; Smyth JF; Mullen P; Miller WR; Langdon SP
Br J Cancer; 1999 May; 80(5-6):685-92. PubMed ID: 10360644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
